BamSEC and AlphaSense Join Forces
Learn More

Celldex Therapeutics Inc.

NASDAQ: CLDX    
Share price (12/30/24): $25.12    
Market cap (12/30/24): $1.667 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 1 page Amendment No. 2 to Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan Dated: April 12, 2024
12/34/56
EX-10.1
from 8-K 1 page Amendment to Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan Dated: April 11, 2023
12/34/56
EX-10.2
from 10-Q 6 pages Tenth Amendment to Lease
12/34/56
EX-10.1
from 10-Q 41 pages Fourth Amended and Restated License Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Third Amendment of Lease
12/34/56
EX-10.1
from 8-K 10 pages Confidential Settlement Agreement and Mutual Release
12/34/56
EX-10.1
from 8-K 4 pages Binding Settlement Term Sheet
12/34/56
EX-10.10
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.9
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.8
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.7
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.6
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.5
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.4
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.3
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.2
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 10 pages Amended and Restated Employment Agreement
12/34/56
EX-10.5
from 8-K 6 pages Restricted Stock Unit Award Agreement Celldex Therapeutics, Inc
12/34/56
EX-10.4
from 8-K 6 pages Nonqualified Stock Option Grant Agreement Celldex Therapeutics, Inc
12/34/56
EX-10.3
from 8-K 6 pages Incentive Stock Option Grant Agreement Celldex Therapeutics, Inc
12/34/56